Patent intelligence · US
US 11932695
Modified antibodies and related compounds, compositions and methods of use
Modified antibodies and related compounds, compositions and methods of use
Patent details — US 11932695
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 19, 2024
- Expiration
- Mar 14, 2044
- Applicant
- Sensei Biotherapeutics, Inc.
- Claims
- 6
- CPC classes
- A61K, A61K47/54, A61K47/545, A61P
Quick answer
US 11932695 (Modified antibodies and related compounds, compositions and methods of use) is held by Sensei Biotherapeutics, Inc.. Status: granted. Granted Mar 19, 2024. Expires Mar 14, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Sensei Biotherapeutics, Inc.
- Grant date
- Expiration
- Claims
- 6
- CPC classes
- A61K, A61K47/54, A61K47/545, A61P, A61P35/00
Frequently asked questions
What is US patent 11932695?
US 11932695 (Modified antibodies and related compounds, compositions and methods of use) is held by Sensei Biotherapeutics, Inc.. Status: granted. Granted Mar 19, 2024. Expires Mar 14, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11932695?
Sensei Biotherapeutics, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 1 pharmaceutical patents for this assignee.
When does US 11932695 expire?
Our index shows an expiration date of Mar 14, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.